Product
Jinshuibao
1 clinical trial
2 indications
Indication
Type 2 Diabetes MellitusIndication
Diabetic NephropathyClinical trial
Efficacy and Safety of Jinshuibao Capsule as Add-on Therapy to Angiotensin II Receptor Blockers on Diabetic Kidney Disease in Patients With Type 2 Diabetes MellitusStatus: Completed, Estimated PCD: 2020-09-26